4-(Pyrrolidin-1-yl)pyridine-2-carboximidamide dihydrochloride

Catalog No.: 
ACHGHU478
CAS No.: 
1803604-36-5
Molecular Formula: 
C10H16Cl2N4
Molecular Weight: 
263.17
4-(Pyrrolidin-1-yl)pyridine-2-carboximidamide dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$245.00InquiryInquiry
100mg95%$358.00InquiryInquiry
250mg95%$505.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Pyrrolidin-1-yl)pyridine-2-carboximidamide dihydrochloride
IUPAC Name4-(pyrrolidin-1-yl)picolinimidamide dihydrochloride
MDL No.MFCD27980910
Molecular FormulaC10H16Cl2N4
Molecular Weight263.17
SMILESN=C(C1=NC=CC(N2CCCC2)=C1)N.[H]Cl.[H]Cl
InChI KeyUVLGOXMBJSQVSY-UHFFFAOYSA-N
Synonym4-(pyrrolidin-1-yl)pyridine-2-carboximidamide dihydrochloride
CAS No.1803604-36-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHGHU478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGHU478 route product structure diagram
    ACHGHU4781803604-36-5
Inquiry

2. ACHGHU478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHGHU478 route product structure diagram
    ACHGHU4781803604-36-5
Inquiry

3. ACHGHU478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGHU478 route product structure diagram
    ACHGHU4781803604-36-5
Inquiry

Comments (0)